Hirt, C., Hoster, E., Unterhalt, M., Hänel, M., Prange-Krex, G., Forstpointner, R., Florschütz, A., Graeven, U., Frickhofen, N., Wulf, G., Lengfelder, E., Lerchenmüller, C., Schlag, R., Dierlamm, J., Fischer von Weikersthal, L., Ahmed, A., Harich, H., Rosenwald, A., Klapper, W., Dreyling, M., Hiddemann, W., & Herold, M. (2021). rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group. HemaSphere, 5(7), e600–. http://access.bl.uk/ark:/81055/vdc_100145486180.0x000001